Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Grifols Biomat Employee Portal"

11:27 EDT 24th July 2014 | BioPortfolio

Original Source: Grifols, Inc.

Currently, we supply plasma products, diagnostic reagents, automated analyzers and dosing machines.In 1998, Grifols established a joint venture with a US diagnostic company, Quest International. Then, in 2000 in order to prepare for an even greater presence in the USA with its plasma products, Grifols founded Grifols USA.Grifols acquired SeraCare’s network of 45 plasmapheresis centers in 2002, thereby vertically integrating the company and guaranteeing its supply of plasma. A year later, Grifols acquired...

Matching Channels

Matching News

Annual Report for 2013 on Form 20-F filed with the SEC on April 4, 2014

BARCELONA, Spain, April 4, 2014 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), announced that it has filed its 2013 Annual Report on Form 20-F with the United Sta...

Grifols, Governor McCrory, And Dignitaries Open State-Of-The-Art Facility In Clayton, NC On June 17

Grifols North Fractionation Facility will be Home to 200 Employees and Help Advance Treatment of Rare and Life-Threatening Diseases WHAT:Grifols, along with North Carolina Governor Pat McCrory, el...

Spain's Grifols completes $5.5 bln refinancing

MADRID, March 17 (Reuters) - Spanish blood products company Grifols said on Monday in a statement to the stock market regulator that it had finalised a $5.5 billion debt restructuring plan.

Grifols chairman backs Catalan independence movement

MADRID, April 3 (Reuters) - The head of Spain's largest pharmaceutical company, Grifols, on Thursday became one of the first executives of a major corporation to back a Catalan leader seeking a refere...

Spain's Grifols sells $1 bln of 2022 bond with 5.25 pct coupon

MADRID, March 5 (Reuters) - Spanish blood products group Grifols sold $1 billion euros of a 2022 bond at a coupon of 5.25 percent on Wednesday, the company said in a statement to the stock market regu...

Spain's Grifols Q1 net profit grows 33 percent

May 6 (Reuters) - Spanish pharmaceutical company Grifols , the world's third-largest blood products maker, posted a 32.9 percent rise in first-quarter net profit on Tuesday to 121 million euros ($168...

Grifols signs 7-yr contract with Japan's Red Cross for $375 mln

MADRID, March 31 (Reuters) - Spanish blood products company Grifols has signed a 7-year, $375-million contract to conduct blood analysis for Japan's Red Cross, the company said in a statement to the s...

Spain's Grifols 2013 net profit up 34.6 percent

MADRID, Feb 27 (Reuters) - Spanish pharmaceutical company Grifols, the world's third-largest blood products maker, reported on Thursday a 34.6 percent year-on-year rise in 2013 net profit to 345.6 mil...

Matching PubMed Articles

Shift Work and Employee Fatigue: Implications for Occupational Health Nursing.

Long work hours and irregular shifts are part of the nation's 24-hour society and contribute to employee fatigue. Factors affecting employee fatigue are circadian rhythm, sleep quality and quantity, i...

Portal hypertension: A critical appraisal of shunt procedures with emphasis on distal splenorenal shunt in children.

Extrahepatic portal venous obstruction (EHPVO) is the most common cause of pediatric portal hypertension. We analyzed the investigative protocol and results of portosystemic shunts in this group of pa...

Portal inflow preservation during portal diversion in small-for-size syndrome.

To investigate the impact of portal inflow on liver remnants in a stable pig model of small-for-size syndrome.

Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

Intrahepatic portal hypertension accounts for most of the morbidity and mortality encountered in patients with liver cirrhosis, due to increased portal inflow and intrahepatic vascular resistance. Mos...

Gastric Coronary Vein to Portal Vein Reconstruction in Liver Transplant: Case Report.

Portal vein thrombosis is a common complication in end-stage liver diseases of candidates for liver transplant. Most portal vein thromboses can be removed with thrombectomy. However, if the thrombosis...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement